Also on this list
ShedRx
A disclosed price ladder — but "as low as" is the 12-month rate, not the real one.
Another provider on our GHK-Cu provider ranking.
Read the ShedRx review →Provider review
Idgie Health lists sermorelin at $179/mo (advertised as $160/mo on a 3-mo prepay), tirzepatide at $229/mo (advertised as $172/mo on a 6-mo prepay) and semaglutide at $149/mo (advertised as $115/mo on a 6-mo prepay), plus 3 more below. Prices checked October 2026.
Month-to-month price first on every page; nearly every prepay saving adds up exactly.
Each product page leads with the one-month rate and prints the 3- and 6-month plans as billed totals. Only the NAD+ six-month tier fails to add up.
Transparency scorecard
3 of 4 disclosed openly
What Idgie Health discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Disclosed
Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit Idgie HealthPharmacy
503A pharmacy
Labs
Not mentioned as a requirement or a cost.
States
All 50 states
Also on this list
ShedRx
A disclosed price ladder — but "as low as" is the 12-month rate, not the real one.
Another provider on our GHK-Cu provider ranking.
Read the ShedRx review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Sermorelin | $160/mo on a 3-mo prepay | $179/moHigher than advertised | 503A pharmacy | October 2026 |
| Tirzepatide | $172/mo on a 6-mo prepay | $229/moHigher than advertised | 503A pharmacy | October 2026 |
| Semaglutide | $115/mo on a 6-mo prepay | $149/moHigher than advertised | 503A pharmacy | October 2026 |
| NAD+ | $160/mo on a 6-mo prepay | $179/moHigher than advertised | 503A pharmacy | October 2026 |
| Glutathione | $133/mo on a 3-mo prepay | $149/moHigher than advertised | 503A pharmacy | October 2026 |
| GHK-Cu | $122/mo on a 3-mo prepay | $145/moHigher than advertised | 503A pharmacy | October 2026 |
What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — One tier does not add up. The NAD+ six-month card reads "save $147" at "$154/mo" for "$960 billed today": $960 over six months is $160 a month, and six months at $179 less $960 is a saving of $114. Every plan also renews automatically for the same length until you cancel, so a six-month plan bills its full total again at month seven.
See plans at Idgie HealthPrices read from Idgie Health's own site
What they advertise
Each product leads with a "From" figure that is its longest prepay tier ("From $171/month" on tirzepatide, "From $114/month" on semaglutide), with the full ladder immediately below it.
What you actually pay
$229/mo tirzepatide, $149/mo semaglutide, $179/mo sermorelin injection, $179/mo NAD+, $149/mo glutathione and $145/mo for the 2% GHK-Cu cream, each one month at a time. Tirzepatide's tiers are $557 for three months and $1,029 for six; semaglutide's are $387 and $687. Oral semaglutide is $287/mo and sermorelin troches $147/mo. Every plan includes the evaluation, medication, supplies, a titration schedule, unlimited provider messaging and shipping.
Money you will meet later
Feel Better Health Group, trading as Idgie Health, sells compounded tirzepatide at $229 a month, semaglutide at $149, sermorelin at $179, NAD+ at $179, glutathione at $149 and a GHK-Cu cream at $145, each with its month-to-month rate first and its prepay plans beside it as real billed totals. It names its pharmacy (VialsRX in Houston) and its medical group (Arora Health & Aesthetics, with a named physician and NPI), says every prescription ships from a 503A pharmacy, and serves all fifty states. Two things to check: its NAD+ six-month tier prints three figures that do not agree, and its shipping policy contradicts the free two-day shipping its product pages promise.
Idgie Health appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking, our Glutathione provider ranking, our GHK-Cu provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Idgie Health names pharmacy partners and states a compounding category. Confirm which partner will fill your prescription.
Named, and categorized on every product page. Its partner-pharmacy page names VialsRX at 6220 Westpark Drive, Houston, Texas, with a phone number, and each product page says an approved prescription "is shipped from a licensed U.S. 503A pharmacy". Clinical care comes from Arora Health & Aesthetics, LLC in Seattle, with Dr. Sean Arora named alongside his NPI. VialsRX at that address is also the named pharmacy of several other storefronts here (Renlo Health, Rylo Health, Voxy and Trimi among them), so those are not independent of each other where it matters clinically.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
All fifty, on a dedicated state-availability page, qualified with a note that specific medications and fulfillment options can vary by state.
The part they would rather you skipped
Idgie Health's NAD+ page contains three numbers that cannot all be true and a sentence about the wrong drug. The six-month card reads "6-month supply, save $147 / $154 /mo / $960 billed today, then every 6 months". Divide $960 by six and you get $160, not $154. Subtract $960 from six months at its own $179 rate and you save $114, not $147. Every other tier on the site reconciles exactly. Further down the same page, the panel headed "About compounding" opens: "Tirzepatide is compounded by state-licensed pharmacies to your provider's specification." The second problem is shipping. Every product page promises free shipping within two business days of approval; its shipping policy says shipping charges are calculated at checkout, delivery averages 4 to 12 business days, and it is not liable for packages damaged or lost in transit.
Other providers on our GHK-Cu provider ranking — the closest match to what Idgie Health sells.




13 more providers are on our GHK-Cu provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Idgie Health's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Idgie Health's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Idgie Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Idgie Health
6 compounds from $145/mo